IDSA: Vaccination Less Likely With Increasing Social Vulnerability, Black Race
By Elana Gotkine HealthDay Reporter
FRIDAY, Oct. 18, 2024 -- Vaccination for influenza, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and respiratory syncytial virus (RSV) is less likely with an increasing social vulnerability index (SVI) and Black race, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in Los Angeles.
Zainab Albar, M.B.B.S., Ph.D., from Case Western Reserve University in Cleveland, and colleagues analyzed data from patients with acute respiratory infections and examined the connection of SVI and race with vaccination rates for influenza, SARS-CoV-2, and RSV. The cohort included a diverse population of 341,029 individuals (81 percent White).
The researchers found that vaccination rates decreased as the SVI quartile increased, especially among Black individuals. In addition, with higher SVI quartiles, there were increases in emergency visits for acute respiratory infections and decreases in primary care visits. As the SVI quartile increased, the likelihood of vaccination decreased, especially among Black people; Black individuals had lower odds of receiving a flu vaccine in all SVI quartiles. The odds of receiving SARS-CoV-2 and RSV vaccines were also lower for Black versus White individuals in all SVI quartiles.
"Disparities this vast are not to be overlooked -- they require multifaceted interventions that meet people where they are socially and increase access to essential preventive measures," coauthor Elie Saade, M.D., M.P.H., from the University Hospitals of Cleveland, said in a statement.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Further Support and Information on COVID-19
Read this next
70 Percent Say They Would Conduct At-Home Test for Suspected COVID-19
WEDNESDAY, July 2, 2025 -- Seventy percent of U.S. adults would conduct a home test for suspected COVID-19, according to a study published online June 30 in JAMA Network...
2023 to 2024 COVID-19 Vaccine Provided Additional Effectiveness
WEDNESDAY, July 2, 2025 -- The 2023 to 2024 COVID-19 vaccine provided additional effectiveness against medically attended COVID-19, according to a study published online June 24...
Wildfire-Induced Changes in Behavior Affect Spread of Airborne Disease
WEDNESDAY, June 25, 2025 -- Wildfire-induced deterioration of air quality leads to a substantial increase in indoor activities, fostering conditions conducive to transmission of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.